Bridgebio Oncology Therapeutics, Inc.
BBOT
Revenue
0.00
0.000.00%
-Assets
448.38M
▼-36.41M▼-7.51%
3 Months ChangeLiabilities
37.29M
▼-808.00k▼-2.12%
3 Months ChangeFree Cash Flow
-114.50M
▼-59.42M▼-107.89%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001193125-26-093997
2026-01-07
Form 8-K
ID: 0001193125-26-005425
2025-11-12
Form 10-Q
ID: 0001193125-25-277834
2025-11-12
Form 8-K
ID: 0001193125-25-277601
2025-08-13
Form 8-K
ID: 0001213900-25-075190
2025-08-06
Form 8-K
ID: 0001213900-25-072312
2025-08-04
Form 8-K
ID: 0001213900-25-071392
2025-08-01
Form 10-Q
ID: 0001213900-25-070659
2025-07-11
Form 8-K
ID: 0001213900-25-062955
2025-05-15
Form 10-Q
ID: 0001213900-25-044424